Trexquant Investment LP Grows Stock Holdings in Trupanion, Inc. (NASDAQ:TRUP)

Trexquant Investment LP boosted its position in Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 229.3% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 138,109 shares of the financial services provider's stock after purchasing an additional 96,174 shares during the quarter. Trexquant Investment LP owned approximately 0.33% of Trupanion worth $6,657,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. SBI Securities Co. Ltd. purchased a new stake in Trupanion during the fourth quarter valued at approximately $25,000. Jones Financial Companies Lllp boosted its position in shares of Trupanion by 71.7% in the 4th quarter. Jones Financial Companies Lllp now owns 570 shares of the financial services provider's stock worth $27,000 after purchasing an additional 238 shares in the last quarter. Wilmington Savings Fund Society FSB purchased a new position in Trupanion during the 3rd quarter worth $54,000. KBC Group NV acquired a new position in Trupanion during the 4th quarter valued at about $75,000. Finally, R Squared Ltd purchased a new stake in Trupanion in the fourth quarter valued at about $79,000.

Trupanion Stock Performance

NASDAQ:TRUP traded up $4.83 during mid-day trading on Wednesday, hitting $37.74. The company's stock had a trading volume of 1,387,003 shares, compared to its average volume of 656,661. The business's fifty day moving average is $38.33 and its two-hundred day moving average is $45.89. The stock has a market cap of $1.60 billion, a price-to-earnings ratio of -164.09, a PEG ratio of 6.02 and a beta of 1.66. Trupanion, Inc. has a 1 year low of $19.69 and a 1 year high of $57.90. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.71 and a quick ratio of 1.66.

Remove Ads

Trupanion (NASDAQ:TRUP - Get Free Report) last announced its quarterly earnings results on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.06 by ($0.02). Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. The company had revenue of $337.31 million for the quarter, compared to analysts' expectations of $335.41 million. Analysts anticipate that Trupanion, Inc. will post 0.13 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the stock. Piper Sandler cut their price objective on shares of Trupanion from $57.00 to $52.00 and set an "overweight" rating on the stock in a report on Thursday, February 20th. Stifel Nicolaus decreased their price target on shares of Trupanion from $44.00 to $41.00 and set a "hold" rating for the company in a report on Thursday, February 20th. Two investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $46.60.

Insider Buying and Selling

In other news, insider Brenna Mcgibney sold 5,000 shares of the firm's stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $32.99, for a total transaction of $164,950.00. Following the sale, the insider now directly owns 3,738 shares in the company, valued at $123,316.62. This trade represents a 57.22 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Margaret Tooth sold 4,000 shares of the company's stock in a transaction dated Thursday, March 20th. The stock was sold at an average price of $37.17, for a total value of $148,680.00. Following the completion of the transaction, the chief executive officer now directly owns 118,784 shares of the company's stock, valued at $4,415,201.28. The trade was a 3.26 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 29,792 shares of company stock valued at $989,442. Corporate insiders own 5.50% of the company's stock.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.